Title
Category
Credits
Event date
Cost
Patient-Centered Treatment Strategies to Improve Outcomes in Schizophrenia
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotherapy
  • Schizophrenia/ Schizoaffective Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Can a patient-centered approach to treatment be adopted for patients with schizophrenia? Can these patients take part in shared decision-making? Follow along as Dr Harvey shares his expertise.
Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options
  • Antipsychotics
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • Treatment Resistance
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Two experts offer a refresher on predictors and identification of treatment-resistant schizophrenia. Drs Correll and Howes also review therapeutic strategies.
Part 3: Impact of Side Effects on Adherence to Schizophrenia Treatment
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Side effects from medication have the greatest impact on adherence for patients with Schizophrenia. They lower quality of life, daily functioning, and satisfaction.
Part 2: Chasing Cognitive and Negative Symptoms: Unmet Treatment Needs of Patients with Schizophrenia
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder’s reward circuitry can help with intervention and patients’ leading more fulfilling lives.
Individualizing Treatment Selection for Pediatric and Adult Patients With Bipolar Depression
  • Bipolar Disorder
  • Depression
  • Antidepressants
  • Antipsychotics
  • Child and Adolescent Psychiatry
  • Diagnostic Tools
  • Mood Disorders
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
  • Bipolar Disorder
  • Antipsychotics
  • Women’s Mental Health
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
Addressing Patients’ Unmet Needs to Improve Outcomes in Schizophrenia
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Patients may be more willing to accept some adverse effects than others. Dr Kane offers advice on addressing side effects that prevent patients from maintaining their medication adherence.
Measurement-Based Diagnosis and Treatment for Tardive Dyskinesia
  • Bipolar Disorder
  • Depression
  • Antipsychotics
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Experts offer a review of the fundamentals of diagnosing and treating tardive dyskinesia.
Part 1: A Review of Schizophrenia
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Schizophrenia affects 1% of the world’s population largely during a patient’s most productive years. Multiple treatments are available, however many gaps to recovery exist. Learn from experts diagnostic criteria for and defining recovery in schizophrenia.

Pages